Business Case Studies, Microeconomics Case Study, European Drug Pricing,Implications

print page
Tell A Friend
Bookmark
 

Case Categories

Microeconomics Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

European Drug Pricing and its Implications

Publication Year : 2004

Authors: Sardhi Kumar Gonela & Sumit Kumar Chaudhuri

Industry: Health Care

Region:Europe

Case Code: MBM0004

Teaching Note: Not Available

Structured Assignment: Not Available

Buy This Case Study
OR





Abstract:
Due to lower drug prices in the European Union (EU), by the turn of the 21st century the per capita spending on drugs in Europe had been much less when compared to that in the US. Lower drug prices in Europe had resulted in cumulative savings of $1 trillion since 1992. Although such huge savings were apparently lucrative, it was opined that Europe would be losing out to the US in the long run as higher drug prices in the US made it a more lucrative market for the drug makers. It was also opined that due to a higher probability of realising the money invested in the research and development of new drugs in the US, more and more drug manufacturers would shift their research centres to the US resulting in research and development job losses in Europe.

Pedagogical Objectives:

  • To discuss the underlying causes for price distortions between the EU and US
  • To discuss how the European drug pricing regulations can be detrimental to the long-term health of the European drug industry .

Keywords : European Union,Government and Business Environment Case Study, Lipitor, Drug price regulations in Europe, Health care systems in Europe, National Health Services in Europe, Reference pricing, Profit regulation, Product price controls,Business Environment Case Study, New molecular entities (NMEs), Research and development (R&,D) investments in European drug industry, Pfizer Inc, Tamoxifen, Novartis, Monopsonist price setter, Drug price distortions

Recently Bought Case Studies

    Recently Bought Case Studies
advertisement

    Executive Interviews

  • Dr. Michael HammerDr. Michael Hammer

    Visiting Professor at MIT and a Fellow at Oxford University.
    Speaks on Change Management
  • Jeanne M BrettJeanne M Brett

    DeWitt W Buchanan, Jr., Professor of Dispute Resolution and Organizations at Kellogg School of Management, Northwestern University.
    Speaks on Multicultural Teams
  • Prof. Kai-Alexander SchlevogtProf. Kai-Alexander Schlevogt

    Professor of international strategy and leadership at the National University of Singapore (NUS) Business School. He serves as Program Director of the Nestle Global Leadership Program, delivered in association with London Business School.
    Speaks on Emerging Markets
  • View All Executive Interviews»




Contact us: IBS Case Development Centre, Survey No. 156/157, Dontanapalli Village, Shankerpalli Mandal, Ranga Reddy District, Hyderabad-501504, Andhra Pradesh, INDIA, Phone: 08147-236660/61/62/72, Fax: 08147-236653,E-mail: casehelpdesk@ibsindia.org

©2003-2013 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap